The regulation of leukemia inhibitory factor.

Leukemia inhibitory factor (LIF), a secreted cytokine, plays an important role in a wide array of biological processes including inducing differentiation of leukemia cell, inflammatory response, neuronal development, embryonic implantation, stem cell self-renewal and cancer progression, etc. LIF exerts its biological functions mainly through the activation and regulation of JAK/STAT3, AKT, EKR1/2 and mTOR signal pathways. The expression levels of LIF are regulated by many different factors under different conditions in different tissue/cell types. For example, estrogen and p53 are important regulators for the high LIF production in uterine tissues at the implantation stage. Hypoxia plays a critical role in LIF overexpression in solid tumors. Many cytokines, including IL-6, IL-1β, can also induce the LIF expression and production. In this review, we summarize the current understanding on the transcriptional regulation of LIF under various conditions.

[1]  Wenwei Hu,et al.  HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells , 2015, Oncotarget.

[2]  K. Young,et al.  LIF negatively regulates tumor suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers , 2014, Nature Communications.

[3]  N. Giribabu,et al.  Leukemia Inhibitory Factor: Roles in Embryo Implantation and in Nonhormonal Contraception , 2014, TheScientificWorldJournal.

[4]  S. Tartare-Deckert,et al.  LIF mediates proinvasive activation of stromal fibroblasts in cancer. , 2014, Cell reports.

[5]  Zhen Liu,et al.  LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway , 2014, Oncotarget.

[6]  Ying Liang,et al.  Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. , 2013, The Journal of clinical investigation.

[7]  A. Bosserhoff,et al.  Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma. , 2013, Experimental and molecular pathology.

[8]  H. Hirai,et al.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. , 2011, The Biochemical journal.

[9]  M. García-Delgado,et al.  LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative Neoplasms. , 2011, Genes & cancer.

[10]  S. Metcalfe,et al.  LIF in the regulation of T-cell fate and as a potential therapeutic , 2011, Genes and Immunity.

[11]  P. Tam,et al.  Extrinsic regulation of pluripotent stem cells , 2010, Nature.

[12]  David García-Dorado,et al.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.

[13]  U. Lerner,et al.  IL-1β and TNF-α Regulate IL-6-type Cytokines in Gingival Fibroblasts , 2008 .

[14]  U. Lerner,et al.  IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. , 2008, Journal of dental research.

[15]  A. Levine,et al.  p53 regulates maternal reproduction through LIF , 2007, Nature.

[16]  M. Kashimura,et al.  Induction of prostaglandin E2 production by leukemia inhibitory factor promotes migration of first trimester extravillous trophoblast cell line, HTR-8/SVneo. , 2007, Human reproduction.

[17]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[18]  S. Bertolone,et al.  Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. , 2007, Cancer research.

[19]  U. Markert,et al.  Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. , 2005, The international journal of biochemistry & cell biology.

[20]  A. Smith,et al.  Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. , 2004, Molecular endocrinology.

[21]  A. Bamberger,et al.  Regulation of the Human Leukemia Inhibitory Factor Gene by ets Transcription Factors , 2003, Neuroimmunomodulation.

[22]  T. Misteli,et al.  Signalling , cell cycle and pluripotency in embryonic stem cells , 2002 .

[23]  A. Turnley,et al.  Cytokines that Signal Through the Leukemia Inhibitory Factor Receptor‐β Complex in the Nervous System , 2000, Journal of neurochemistry.

[24]  D. Knight,et al.  Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. , 1999, American journal of respiratory cell and molecular biology.

[25]  J. Déchanet,et al.  Leukemia inhibitory factor: part of a large ingathering family. , 1998, International reviews of immunology.

[26]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[27]  J. Williams,et al.  Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. , 1994, The American journal of physiology.

[28]  T. Matsui,et al.  Expression and regulation of the leukemia inhibitory factor/D factor gene in human T-cell leukemia virus type 1 infected T-cell lines. , 1992, Cancer research.

[29]  C. Stewart,et al.  Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.

[30]  R. Kurzrock,et al.  Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. , 1991, Experimental hematology.

[31]  D. Hilton,et al.  Structural characterization of a murine myeloid leukaemia inhibitory factor. , 1988, European journal of biochemistry.

[32]  A. Kelso,et al.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). , 1987, The EMBO journal.